| Author | Santos, Alanna Calheiros | |
| Author | Paula, Vanessa Salete de | |
| Author | Miguel, Juliana Custódio | |
| Author | Silva, Elisangela Ferreira da | |
| Author | Pinto, Laura Cristina Machado | |
| Author | Lewis- Ximenez, Lia Laura L. | |
| Author | Villar, Lia Laura | |
| Access date | 2022-02-07T13:56:57Z | |
| Available date | 2022-02-07T13:56:57Z | |
| Document date | 2021 | |
| Citation | SANTOS, Alanna Calheiros et al. P-87 High prevalence of SARS-COV-2 antibodies in pregnant women infected with Viral Hepatitis in Brazil. Annals of Hepatology, v. 24, 100366, p. 1- 2, 2021. | pt_BR |
| ISSN | 1665-2681 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/51047 | |
| Language | eng | pt_BR |
| Publisher | Medica Sur Clinical Foundation | pt_BR |
| Rights | open access | |
| Subject in Portuguese | COVID-19 | pt_BR |
| Subject in Portuguese | SARS-COV-2 | pt_BR |
| Subject in Portuguese | Grávidas | pt_BR |
| Subject in Portuguese | Anticorpos | pt_BR |
| Subject in Portuguese | Infectadas | pt_BR |
| Subject in Portuguese | Hepatites Virais | pt_BR |
| Subject in Portuguese | Brasil | pt_BR |
| Title | P-87 High prevalence of SARS-COV-2 antibodies in pregnant women infected with viral Hepatities in Brazil | pt_BR |
| Type | Article | |
| DOI | 10.1016/j.aohep.2021.100449 | |
| Abstract | Pregnant women are considered more vulnerable
to viral infections, such as severe viral respiratory infections and viral
hepatitis. Data about Brazilian pregnant and postpartum women
found a case fatality rate of 12.7% among COVID-19 Acute Respiratory
Distress Syndrome cases (ARDS). Studies in pregnant women found
prevalences of antibodies (Ab) against SARS CoV-2 between 4 to 14%
in Europe and North America. However, there is no data about the
prevalence of SARS CoV-2 Ab among Brazilian pregnant women with
viral hepatitis. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais, Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais, Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais, Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais, Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais, Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais, Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais, Rio de Janeiro, RJ, Brasil. | pt_BR |
| Subject | COVID-19 | pt_BR |
| Subject | SARS-COV-2 | pt_BR |
| Subject | High prevalence | pt_BR |
| Subject | Pregnant women | pt_BR |
| Subject | Infected | pt_BR |
| Subject | Viral Hepatitis | pt_BR |
| Subject | Brazil | pt_BR |
| xmlui.metadata.dc.subject.ods | 05 Igualdade de gênero | |
